Fred Hassan Bridge Bio Pharma, Inc. (BBIO) insider trading activity

BBIO Quotes by TradingView

Fred Hassan is of BridgeBio Pharma, Inc.. Currently has a direct ownership of 25,889 shares of BBIO, which is worth approximately $1.19 Million. The most recent transaction as insider was on Jun 20, 2025, when has been sold 6,589 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.9K
34.14% 3M change
34.14% 12M change
Total Value Held $1.19 Million

Fred Hassan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2025
BUY
Grant, award, or other acquisition
-
6,589 Added 20.29%
25,889 Common Stock
Dec 29 2021
BUY
Open market or private purchase
$273,481 $14.17 p/Share
19,300 Added 50.0%
19,300 Common Stock

Also insider at

AMGN
AMGEN INC Healthcare
Director
PGEN
PRECIGEN, INC. Healthcare
Director
RXDX
Prometheus Biosciences, Inc. Healthcare
Director
COCP
Cocrystal Pharma, Inc. Healthcare
Director
EYPT
EyePoint Pharmaceuticals, Inc. Healthcare
FH

Fred Hassan

Thousand Oaks, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BBIO